Buyers and sellers were not immediately known
Source: Bloomberg
Click here for more stock market statistics
Government official says power PSUs and banks will hold stake in asset reconstruction company under Pariwartan scheme.
Source: Government official to BloombergQuint
A deteriorating EM risk backdrop and pressure on current account deficit currencies has led USD/INR to multi-year highs. We see risk of continued INR depreciation in the near term and enter a short-dated long USD/ INR call spread position, Nomura said in a research report.
Rupee Nears 72/$ As Global, Domestic Risks Build
Shares of the Mumbai-based airline fell as much as 3.2 percent to Rs 263 after Financial Times reported that Jet Airways has failed to pay salary to thousands of staff in August.
Click here to see the complete options chain
The Nikkei India services Purchasing Managers' Index, or PMI, fell to 51.9 in August from July’s 21-month high of 54.1, indicating slower rise.
A reading above 50 indicates economic expansion, while a reading below 50 points toward contraction.
The slowdown was driven by the weakest growth in new work in 3 months, although business confidence rose to the highest level since May.
Source: Nikkei
Shares of the Delhi-based steel maker and power producer fell as much as 4.75 percent to Rs 14.20 after JSW Steel and its promoters acquired around 88 percent stake in the company following completion of the insolvency resolution proceedings, Monnet Ispat said in an exchange filing.
The National Company Law Tribunal (NCLT) had earlier approved a Rs 2,875-crore bid by a consortium of Aion Investments and JSW Steel to acquire the bankrupt Monnet Ispat & Energy, which owes over Rs 11,000 crore to a clutch of lenders.
The Aion-JSW consortium was the sole bidder for the 1.5-million-tonne asset in Chhattisgrah.
Shares of the Kochi-based non-banking finance company rose as much as 5.5 percent, the most in over a month, to Rs 422 after it beat Bloomberg consensus estimates in June quarter.
Key earnings highlights:
Shares of the Mumbai-based advanced pharmaceutical ingredients and generic drugmaker rose as much as 4.86 percent to Rs 404.95.
Sun Pharma Advanced Research Company (SPARC) will file new drug application for cancer drug Taclantis in the fourth quarter of current financial year, the company said in an exchange notification.
SPARC also released deadlines for FDA to review its two new drugs Xelpros and Elepsia in November 2018 and January 2019, respectively.
BloombergQuint spoke to Chandan Taparia, derivatives and technical analyst at Motilal Oswal and below are hist trading strategies for the day.
Nomura on Cochin Shipyard
HDFC Securities on HG Infra
Edelweiss on ITC
Credit Suisse on FMCG
Deutsche Bank on Grasim Industries
Jefferies on GAIL (India)
Citi on ICICI Bank
Macquarie on Graphite India
CLSA on Media
(As reported on Sep. 4)
Dynamatic Technologies
Muthoot Finance Q1 (Standalone, YoY)
Here are some key events coming up this week:
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.